Wealth Is Becoming a Health Advantage
Affluent women are gaining earlier access to longer appointments, private specialists, advanced testing, and emerging treatments. The question is not whether all of it is worth buying.
A friend of mine asks me a version of the same question almost every time we talk:
What are women in California doing now?
She wants to know about the treatments, tests, doctors, beauty procedures, supplements, and longevity practices that seem to appear here before they reach the rest of the country.
It is usually asked lightly.
What are women doing for their skin? Are they taking peptides? Is everyone wearing a continuous glucose monitor? Are those expensive menopause clinics actually better? What are the women who seem to know everything doing that no one has told us about yet?
But underneath her question is a much bigger one.
What do women gain when they can afford to step outside the ordinary healthcare system?
The answer is not simply better health.
Money can buy more time with a physician. It can buy faster appointments, broader testing, private specialists, second opinions, health coaching, advanced imaging, aesthetic treatments, and access to clinics built around prevention rather than crisis.
It can also buy unnecessary tests, aggressive treatment, false reassurance, and very expensive versions of things that are available elsewhere for much less.
Early access is not the same as good evidence.
Luxury is not the same as medicine.
And expensive does not automatically mean effective.
Still, it would be a mistake to dismiss everything wealthy women are buying as vanity or indulgence.
They may be showing us where healthcare is going next.
The healthcare system most women experience
For many women, healthcare remains fragmented.
One physician manages hormones. Another handles cardiovascular risk. A third discusses bone health. Sleep, sexual health, metabolism, mood, muscle loss, and cognitive concerns may be treated as unrelated issues, assuming they are addressed at all.
The conventional appointment was rarely designed to connect these pieces.
American healthcare is extraordinarily expensive, yet the country continues to face shortages in primary care and weaker access than many peer nations. In 2024, the United States spent approximately 18% of its gross domestic product on healthcare, nearly twice the average among comparable countries. At the same time, the country had one of the lowest rates of primary care physicians per capita in the comparison.
That combination produces an uncomfortable reality:
We spend more, yet many patients still struggle to obtain enough time, continuity, and coordination.
Women often feel this most sharply in midlife.
The symptoms do not arrive neatly labeled. Sleep changes. Anxiety appears without an obvious cause. Weight shifts. Muscle disappears faster. Cholesterol rises. Sex becomes painful. Energy drops. The brain feels less reliable.
A woman may visit several professionals and receive several isolated answers.
She is told to reduce stress.
Lose weight.
Sleep more.
Try an antidepressant.
Buy supplements.
Come back if it gets worse.
What she often does not receive is someone willing to look across the entire picture.
What private money actually buys
At its best, private healthcare buys something surprisingly ordinary:
Attention.
It may provide:
A longer initial consultation
Faster access to a clinician
More continuity with the same physician
Coordination among specialists
Time to discuss family history and long-term risk
Help organizing records and prior findings
Follow-up after a test or treatment
A clearer explanation of available options
A clinician who is paid to think before the situation becomes urgent
The number of concierge and direct-primary-care practices in the United States increased from 1,658 in 2018 to 3,036 in 2023, an increase of more than 83%. The number of participating clinicians rose by approximately 78% during the same period.
That growth is not proof that concierge care produces superior outcomes. The models vary widely, as do their prices, services, and clinical quality.
But it does reveal demand.
Patients are willing to pay separately for something they believe the standard system is not reliably providing.
In many cases, that something is not a revolutionary therapy.
It is time, access, explanation, and a person who knows what happened at the last appointment.
Wealth also buys experimentation
The private-care market is not limited to longer physician visits.
Affluent women are being offered:
Full-body MRI scans
Extensive biomarker panels
Biological-age testing
Continuous glucose monitors
Genetic and multi-cancer screening tests
Concierge menopause programs
Executive physicals
Personalized supplement protocols
Peptides and hormone “optimization”
Brain-health assessments
Advanced skin and body treatments
Longevity memberships costing thousands of dollars a year
Some of these services are supported by established medical evidence for particular patients.
Some are promising but still emerging.
Some provide information without a clear path to action.
Some are conventional healthcare repackaged with better lighting, softer robes, and a larger price.
And some are being marketed far ahead of the science.
That is where the conversation becomes more complicated.
Wealth can allow a woman to act earlier. It can also expose her to more interventions, more incidental findings, more conflicting recommendations, and more opportunities to be sold something.
More information does not always create more clarity.
More testing does not always improve health.
Sometimes it creates a new category of patient: a person who felt well until a scan found something that may never have mattered.
Women are looking, but they do not necessarily trust what they find
Women are already active consumers of health information and digital healthcare.
Rock Health found that more than half of women surveyed had used virtual care, tracked health metrics digitally, or owned a wearable or connected health device. Yet only 7% completely trusted health information from websites and apps, and only 5% completely trusted health information found on social media.
That gap matters.
Women are searching because they have questions the healthcare system has not answered adequately.
But they are searching in an environment where physicians, founders, influencers, supplement companies, wellness clinics, medical-device manufacturers, affiliate marketers, and investors may all be talking about the same treatment for very different reasons.
A polished recommendation may be:
A clinical opinion
An early scientific hypothesis
A personal testimonial
A sponsored placement
A sales funnel
An affiliate link
A treatment being sold by the person explaining why it is necessary
Those distinctions are rarely obvious in an Instagram Reel.
Women’s health is still an underbuilt market
Women represent roughly half the population, but women’s health has historically received a disproportionately small share of healthcare investment.
A 2026 World Economic Forum analysis found that women’s health captured only about 6% of private healthcare investment. Approximately 90% of that limited investment remained concentrated in women’s cancers, reproductive health, and maternal health.
That leaves major areas of women’s lives comparatively underdeveloped:
Menopause
Cardiovascular disease
Brain health
Autoimmune disease
Bone health
Sexual health
Pelvic health
Metabolic health
Conditions that present differently in women
The long period between reproductive care and elder care
Private clinics and health companies are moving into these gaps.
Some will create meaningful care models.
Others will recognize a frustrated, affluent customer and build an expensive product around her fear.
Often, both things will be true at the same time.
Women have spent generations being expected to tolerate discomfort, manage everyone else’s healthcare, and remain grateful for whatever attention they receive.
I have no interest in telling a woman she is frivolous because she wants to feel better, look better, preserve her strength, protect her brain, or understand what is happening in her body.
I also do not believe women should be shamed for purchasing convenience.
Time has value.
Being listened to has value.
A physician who responds has value.
A calm, organized experience has value.
But we should be able to distinguish what we are purchasing.
Are we buying:
Better medical care?
More physician time?
Faster access?
Greater convenience?
More privacy?
Reassurance?
A luxury experience?
An intervention that improves an outcome?
Or a compelling promise that has not yet been proven?
There is nothing wrong with buying comfort or convenience.
The problem begins when comfort is presented as clinical superiority or when possibility is marketed as certainty.
This is what The Everwell Edit will investigate
I am interested in what wealthy women are doing because wealth often provides an early view into what the healthcare market is building next.
But I will not assume that what they are doing is automatically better.
I want to know:
What are they buying?
What problem are they trying to solve?
What does it cost?
What does the evidence support?
What remains uncertain?
Who benefits financially?
What are the possible harms?
What questions should a woman ask before paying?
Is there a less expensive way to obtain the same benefit?
Is this likely to become part of mainstream care or disappear with the trend cycle?
I will clearly separate established evidence from emerging evidence, professional interpretation, personal experience, and speculation.
I will also say when the answer is simply: we do not know yet.
Because women do not need another person telling them to buy everything.
They need someone willing to investigate what is being sold.
The real divide
The emerging divide in women’s health is not merely between women who care about wellness and women who do not.
It is between women who have the time, money, connections, and confidence to keep searching, and women who are forced to accept the first incomplete answer.
Wealth can buy access to the future of healthcare.
But the useful lessons from that future should not remain available only to the people who can afford the first version.
That is the purpose of The Everwell Edit.
To look inside the clinics, treatments, technologies, and ideas reaching affluent women first.
To understand what they are paying for.
To separate better care from better marketing.
And to bring the useful information back into the room for everyone else.
Come sit down.
Renée x
What health, beauty, or longevity treatment have you seen wealthy women trying that you want me to investigate? Reply or leave it in the comments.
The Everwell Edit investigates what wealthy women are doing for health, beauty, and longevity, what it costs, what the evidence says, and what may actually be worth it.
Subscribe to receive the next investigation. 🤍